Archived Insight | March 25, 2021

How to Implement the ARPA's COBRA Premium Subsidy

The American Rescue Plan Act of 2021 (ARPA) provides a 100 percent subsidy of COBRA premiums beginning on April 1, 2021, through September 30, 2021, with subsidies being paid to plan sponsors through a payroll tax credit. The government is required to issue model notices required to be sent to participants concerning subsidy eligibility and a new election period no later than April 10, 2021.

This webinar which took place on April 13, 2021, explained how the subsidy works and discussed the guidance published by the government.

Watch the Webinar

Get the slides from this webinar

Don’t have time to watch a video right now? No worries. Here is a copy of the slides.

Download the Slides

Read more insights

Senior Woman Using Digital Tablet While Lying On Couch At Home

DOL Proposes Changes to Benefit Statement Delivery Rules

The DOL proposed updates on when benefit statements must be delivered on paper vs. electronically. See key considerations for DC and DB plan sponsors.

Retirement, Compliance, Multiemployer Plans, Healthcare Industry, Higher Education, Corporate, Communications

Read Full Insight

Young Couple Looking Concerned While Going Through Their Paperwork Together At Home

HHS Updates Model HIPAA Privacy Notices and Complaint Portal

What plan sponsors should review now, including updated notice language, SUD confidentiality protections and the revised complaint filing process.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate

Read Full Insight

Asia Female Pharmacist Using Digital Tablet While Taking Inventory

New Requirements for PBM Reporting and Fee Disclosures

The Consolidated Appropriations Act of 2026 makes significant reforms to pharmacy benefit manager practices. See the impact on health plan sponsors.

Compliance, Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate, Pharmaceutical

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.